Patent Yard Sign in
Expired Canadian patentCanada

Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof

CA 2390164 C · Owner: Wang, Yan · Inventors: Wang, Yan; Drewe, John A.; Cai, Sui Xiong

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention is directed to substituted 4H-chromene and analogs thereof, represented by general Formula (I) wherein A, B, X, Y, Z and , R5 , are defined herein. The present invention also relates to the discovery that com-pounds having Formula (I) are activators of caspases and inducers of apoptosis. , Therefore, the activators of caspases and inducers of apoptosis of this invention , can be used to induce cell death in a variety of clinical conditions in which un-controlled growth and spread of abnormal cells occurs.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 3, 2000 and granted March 29, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 3, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 3, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 3, 2000
GrantedMarch 29, 2011
Term endedNovember 3, 2020
Patent numberCA 2390164 C
Classification (IPC)C07D311/58 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedNov 3, 2000Patent grantedMarch 29, 2011Term endedNov 3, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.